# OnCo record pmv-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/pmv-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "pmv-pharma" ;
  schema:name "PMV Pharma"@en ;
  schema:alternateName "PMV Pharmaceuticals, Inc."@en, "PMV Pharmaceuticals"@en ;
  schema:description "A listed US company developing a pill, rezatapopt, meant to repair one specific faulty form of the p53 protein, a natural brake on cancer. It is for solid tumours of any type that carry the TP53 Y220C mutation."@en ;
  schema:url <https://onco.cc/companies/pmv-pharma/>, <https://www.pmvpharma.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.pmvpharma.com/>, <https://www.pmvpharma.com/pipeline/>, <https://www.pmvpharma.com/about/>, <https://clinicaltrials.gov/study/NCT04585750>, <https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001699382>, <https://www.racap.com/portfolio/pmvpharma> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:targets <https://onco.cc/targets/tp53/> ;
  onco:drugs <https://onco.cc/drugs/rezatapopt/> ;
  onco:trials <https://onco.cc/trials/nct04585750/> .